IMPORTANCE Fibromuscular dysplasia (FMD) is a nonatherosclerotic arterial disease that predominately affects women and is most commonly diagnosed in middle age. The natural history of FMD among patients diagnosed at an older age is not well understood.
F ibromuscular dysplasia (FMD) is nonatherosclerotic arterial disease that predominately affects women. Fibromuscular dysplasia has historically been considered a disease of young women, but data have shown that it can affect all age groups and is most commonly diagnosed in middle age. 1, 2 The prevalence of FMD in the general population is unknown. 3 Some reports suggest it may be as high as 4%, but this is based on data derived from potential living kidney donors, which is subject to selection bias. 3 Clinical manifestations of FMD are determined by location and severity of arterial lesions. Clinical presentation is variable and may be limited to symptoms affecting quality of life, such as headaches and pulsatile tinnitus, or may result in more serious sequelae including arterial dissections and/or aneurysms. 4 Fibromuscular dysplasia has been reported in nearly every arterial bed, although the renal and carotid/vertebral arteries are most commonly involved. 1 In this report, we present baseline data from the US Registry for FMD regarding presenting manifestations, vascular events, and procedures among elderly and younger patients.
Methods
The design of the US Registry for FMD has been previously published; enrollment began in January 2009. , and Fisher exact tests were used to evaluate the differences between the 2 age groups. All P values reported were 2-sided, with a significance level of .05 throughout. This report presents data collected from the baseline data forms for patients enrolled in the registry.
Results
One thousand sixteen patients were included in the analysis. Age distribution is shown in the Figure; 170 [n = 12 of 840]; P = .02). Time lapse between onset of symptoms and diagnosis of FMD was longer in patients 65 years and older (7.2 years vs 3.5 years; P < .001). Headache and pulsatile tinnitus, both common manifestations of FMD, were less common in older patients. In contrast, older patients were more likely to have hypertension as a presenting manifestation of FMD. Older patients were taking more antihypertensive medications at the time of enrollment (median, 2; interquartile range, 1-2 vs median, 1; interquartile range, 0-2; P < .001). Older patients were more likely to have a carotid bruit at the baseline physical examination, but there was no significant difference in presence of bruits at other locations (epigastric, flank, and femoral; data not shown). Patients 65 years or older were less likely to have had a major vascular event (37.1% vs 46.1%; P = .03) at the baseline assessment. There was no significant 
Key Points
Question What are the differences in clinical presentation between elderly (age Ն65 years) and younger patients with multifocal fibromuscular dysplasia?
Findings In this multicenter registry study, elderly patients with multifocal fibromuscular dysplasia were more likely to be asymptomatic and less likely to have had a major vascular event or revascularization procedure.
Meaning Elderly patients with fibromuscular dysplasia may represent a more benign clinical phenotype. difference in history of stroke, renal infarction, or subarachnoid hemorrhage between the 2 age groups. Distribution of arterial bed involvement, aneurysms, and vascular procedures is shown in Table 2 . The extracranial carotid arteries were more commonly involved among older patients. There were no differences in renal, vertebral, mesenteric, or intracranial involvement between the 2 groups. There was no difference in the mean number of arterial beds involved, percentage of patients with more than 1 arterial bed (multivessel) involved, or diagnosis of aneurysm between the 2 age groups. Fewer patients 65 years or older had undergone a therapeutic vascular procedure at baseline assessment.
Discussion
To our knowledge, this study is the first to describe the presentation and clinical features of FMD among patients 65 years or older at time of FMD diagnosis. Patients 65 years and older at the time of diagnosis of FMD had lower frequency of major vascular events and had undergone fewer vascular procedures, although the frequency of multivessel involvement and aneurysms was not significantly different between the groups. These findings suggest the possibility of a milder clinical phenotype of FMD when diagnosed in elderly patients.
Patients 65 years or older at time of diagnosis constituted 16.7% of the study population, which confirms previous data that FMD is a vascular disease of all age groups.
1,2 Savard et al 2 reported that focal and multifocal FMD were associated with different clinical phenotypes and patients with focal FMD were significantly younger than patients with multifocal FMD. As a result, patients with focal FMD were excluded from this analysis. It has been suggested that focal FMD may represent an entirely distinct disease entity than multifocal disease. 6 Headache and pulsatile tinnitus were the most common presenting symptoms of FMD in the US registry. 5 Older patients were less likely to experience these symptoms compared with younger patients, which could potentially contribute to the later age at diagnosis. Furthermore, although few patients were asymptomatic in both age groups, older patients were more likely to be asymptomatic at time of diagnosis and perhaps diagnosed incidentally during imaging studies performed for non-FMD-related reasons. Arterial dissections, including spontaneous coronary artery dissection, have been associated with FMD 4, 7, 8 and are a common mechanism of ischemic events, including MI and stroke, in this patient population. In this cohort, older patients had fewer major vascular events including arterial dissection and MI. Subarachnoid hemorrhage was rare in both age groups. Hypertension was more common in the older patients. While FMD is a known etiology for renovascular hypertension, 9,10 essential hypertension and uncontrolled hypertension are independently associated with age.
11
Multifocal FMD usually involves more than 1 arterial bed, 12, 13 and the percentage of patients with multivessel involvement was similar in both age groups (approximately 60%). Aneurysm is common among patients with FMD and was previously reported in 21.7% of patients in the US registry. 4 Women with FMD have higher prevalence of intracranial aneurysm compared with the general population. 14 In this analysis, aneurysm prevalence was not significantly different in the age groups. While the extracranial carotid arteries were more commonly involved in older patients, involvement of other arterial beds was similar. Given the lower frequency of vascular events, headache, and pulsatile tinnitus among older patients, it is possible that fewer imaging studies were obtained, contributing to a delay in diagnosis of FMD until imaging is performed for another indication. It is not clear how hormonal factors and menopause play a role in FMD. 3 While most patients enrolled in the US Registry for FMD were women, we found no difference in mean age at diagnosis or percentage of patients diagnosed at 65 years or older between female and male patients. Among female patients, there was no difference in age at onset of menopause between those diagnosed at an older or younger age.
Limitations
The study sample is derived from patients enrolled in the US registry for FMD. The registry is subject to referral bias because academic referral centers represent most sites. The elderly population may be underrepresented in the registry because FMD is not usually considered in older patients. Health care clinicians may attribute nonspecific symptoms to the aging process, and elderly patients may not be referred as often for vascular imaging. In contrast, younger patients may be overrepresented because they may be more likely to seek online health information regarding rare diseases and self-refer to a specialty center. Additionally, not all patients underwent assessment of all arterial beds with imaging studies. The mechanism of hypertension (ie, renovascular or essential) and that of vascular events (eg, whether a stroke or MI was owing to dissection or atherosclerotic disease) is not captured in the US registry nor is there centralized imaging or angiogram review. Despite these limitations, we believe that the finding of fewer vascular events in older patients with FMD is important.
Conclusions
In the US Registry for FMD, patients 65 years or older at the time of diagnosis of multifocal FMD were more likely to be asymptomatic, had lower prevalence of major vascular events, and were less likely to have undergone therapeutic vascular procedures at enrollment compared with younger patients. Patients diagnosed as having FMD at an older age may have a more benign disease process and less severe symptoms. Role of the Funder/Sponsor: Pamela Mace, executive director of the FMD Society of America, is a member of the steering committee of the US Registry for FMD and participated in the design of the registry. The sponsor had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
